Steven George Hughes, Chief Officer of Atrium Therapeutics RNA, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $631.1K. The latest trade was on 04/20.

SH

SH

Steven George Hughes

Chief Medical Officer

Company

Atrium Therapeutics RNA

First filing

25/03/21

Trades

44 trades

Buys / sales

0 / 16

12-month net buying

−$631.1K

Last trade

04/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AB Avidity Biosciences	Open-market sale10b5-1 plan	01/21	01/23	4,895 sh2 trades	$72.45avg.	$354,642.75	−13.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	01/07	01/09	2,373 sh	$72.23	$171,401.79	−6.1%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/10/22	25/10/24	2,209 sh	$47.54	$105,015.86	−5.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/09/22	25/09/23	2,208 sh	$40.58	$89,600.64	−5.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/09/15	25/09/17	1,542 sh	$45.41	$70,022.22	−3.8%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/08/22	25/08/22	2,208 sh	$46.40	$102,451.2	−5.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/08/13	25/08/15	1,542 sh	$46.66	$71,949.72	−3.8%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/08/06	25/08/08	81,434 sh5 trades	$42.74avg.	$3,480,489.16	−67.7%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/03/20	25/03/21	9,578 sh	$31.06	$297,492.68	−11.6%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/01/21	25/01/23	3,947 sh2 trades	$28.59avg.	$112,863.88	−4.6%